Search by Drug Name or NDC
NDC 68016-0018-04 Tussin DM 10; 100 mg/5mL; mg/5mL Details
Tussin DM 10; 100 mg/5mL; mg/5mL
Tussin DM is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Chain Drug Consortium, LLC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 68016-0018-04Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 68016-0018-04Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 68016-0018 |
---|---|
Product ID | 68016-018_e01b17a9-936a-4569-8c2d-764aa35d0477 |
Associated GPIs | |
GCN Sequence Number | 000652 |
GCN Sequence Number Description | guaifenesin/dextromethorphan LIQUID 100-10MG/5 ORAL |
HIC3 | B3T |
HIC3 Description | NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION |
GCN | 53491 |
HICL Sequence Number | 000223 |
HICL Sequence Number Description | GUAIFENESIN/DEXTROMETHORPHAN HBR |
Brand/Generic | Brand |
Proprietary Name | Tussin DM |
Proprietary Name Suffix | COUGH SUPPRESSANT/EXPECTORANT |
Non-Proprietary Name | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | ORAL |
Active Ingredient Strength | 10; 100 |
Active Ingredient Units | mg/5mL; mg/5mL |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | Chain Drug Consortium, LLC |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH DRUG |
Application Number | M012 |
Listing Certified Through | 2024-12-31 |
Package
NDC 68016-0018-04 (68016001804)
NDC Package Code | 68016-018-04 |
---|---|
Billing NDC | 68016001804 |
Package | 118 mL in 1 BOTTLE, PLASTIC (68016-018-04) |
Marketing Start Date | 2012-09-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |